Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ACL [NYSE]
Alcon Inc.
Healthcare - Medical Instruments & Supplies - Switzerland
Index- P/E43.86 EPS (ttm)3.59 Insider Own76.00% Shs Outstand304.61M Perf Week-0.92%
Market Cap47.96B Forward P/E21.28 EPS next Y7.40 Insider Trans- Shs Float73.10M Perf Month2.02%
Income1.12B PEG3.81 EPS next Q1.51 Inst Own23.05% Short Float2.58% Perf Quarter7.31%
Sales4.59B P/S10.44 EPS this Y6.43% Inst Trans38.73% Short Ratio1.36 Perf Half Y23.21%
Book/sh18.06 P/B8.72 EPS next Y10.28% ROA22.03% Target Price174.75 Perf Year97.27%
Cash/sh5.38 P/C29.24 EPS next 5Y11.50% ROE44.08% 52W Range73.29 - 166.71 Perf YTD-4.19%
Dividend3.64 P/FCF43.28 EPS past 5Y21.97% ROI37.94% 52W High-5.55% Beta0.25
Dividend %2.31% Quick Ratio1.33 Sales past 5Y11.34% Gross Margin75.72% 52W Low114.84% ATR2.19
Employees15400 Current Ratio1.55 Sales Q/Q11.84% Oper. Margin29.59% RSI (14)51.32 Volatility1.09% 1.19%
OptionableYes Debt/Eq0.33 EPS Q/Q44.06% Profit Margin24.33% Rel Volume0.35 Prev Close156.11
ShortableYes LT Debt/Eq0.02 EarningsFeb 11 AMC Payout3.73% Avg Volume1.39M Price157.46
Recom2.10 SMA201.22% SMA50-0.14% SMA20017.97% Volume490,315 Change0.86%
14-Jan-10Downgrade Citigroup Buy → Hold
07-Jan-10Downgrade UBS Buy → Neutral
15-Jul-09Reiterated Credit Suisse Neutral $95 → $129
10-Jun-09Initiated Sun Trust Rbsn Humphrey Buy $155
24-Apr-09Reiterated Credit Suisse Neutral $92 → $95
15-Apr-09Reiterated Jefferies & Co Buy $96 → $106
25-Feb-09Initiated Credit Suisse Neutral
24-Feb-09Reiterated Collins Stewart Buy $96 → $108
23-Feb-09Downgrade Wachovia Outperform → Mkt Perform
12-Feb-09Reiterated Jefferies & Co Buy $92 → $96
21-Jan-09Upgrade FTN Midwest Neutral → Buy
05-Jan-09Upgrade BMO Capital Markets Market Perform → Outperform
17-Dec-08Initiated Collins Stewart Buy $96
01-Dec-08Upgrade Wachovia Mkt Perform → Outperform
24-Oct-08Reiterated Jefferies & Co Buy $180 → $110
24-Oct-08Reiterated Credit Suisse Neutral $185 → $116
12-May-08Initiated Citigroup Buy
11-Jul-07Initiated Wachovia Outperform
14-Jun-07Initiated Jefferies & Co Buy $159
30-Apr-07Reiterated BMO Capital Markets Outperform $150 → $160
09-Feb-10 03:49PM  [video] 2 Blowout Earnings Reports at TheStreet.com
08-Feb-10 08:40AM  3 Stocks I Saw on TV TheStreet.com TV
05-Feb-10 08:22AM  [video] 3 Stocks I Saw on TV at TheStreet.com
04-Feb-10 09:10PM  Allergan's Looking Real Pretty Right Now at CNBC
03:45PM  Two Pharmas at Forbes.com
10:00AM  NovaBay Pharmaceuticals to Present at the 2010 BIO CEO & Investor Conference Marketwire
02-Feb-10 10:06AM  UPDATE - Novartis: no comment on talk may sell Roche stake at Reuters
01-Feb-10 11:12PM  Big Chill Hit the Deal Market in January at The New York Times
29-Jan-10 05:01PM  Stull, Stull & Brody Files Class Action Suit Against Novartis AG and Nestl S.A. on Behalf of the Public Minority Shareholders of Alcon, Inc. Business Wire
28-Jan-10 03:24PM  Pharma & Biotech Stock Review Zacks.com
27-Jan-10 02:58PM  Nice, Novartis, Very Nice at Motley Fool
12:35PM  AllianceBernstein Takes Aim at Novartis Over Alcon at The New York Times
26-Jan-10 06:31PM  [$$] New Novartis Chief Needs Surgery Skills at The Wall Street Journal Online
06:11PM  [$$] Longtime Novartis CEO Steps Aside at The Wall Street Journal Online
04:03PM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
02:30PM  Novartis says Q4 profit rises 54 pct to $2.32B AP
02:20PM  Vasella to quit joint CEO role at Novartis at FT.com
01:19PM  Alcon Shareholders Push Novartis on Bid at The New York Times
12:45PM  Dr Vasella prescribes good governance pill at Novartis at FT.com
12:23PM  Alcon investor objects to Novartis takeover offer at Reuters
11:15AM  Novartis at FT.com
09:58AM  Novartis Beats Estimates, Brightening Outlook at SmartMoney.com
06:48AM  Novartis names new CEO as profit jumps 50% at MarketWatch
06:46AM  UPDATE - Novartis taps Jimenez as CEO for industry challenges at Reuters
06:13AM  An Injection of Good News For Big Pharma at SmartMoney.com
05:15AM  Britain Sneaks Out Of Recession at Forbes.com
04:15AM  REFILE-UPDATE - Novartis taps Jimenez for industry challenges at Reuters
02:51AM  European Factors -- Shares set to fall; UK GDP eyed at Reuters
01:51AM  UPDATE - Novartis names drugs chief Jimenez new CEO at Reuters
01:23AM  UPDATE - Novartis names drugs chief Jimenez new CEO at Reuters
25-Jan-10 04:07PM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
04:01PM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
03:10PM  Strong Greek banks fail to lift Eurofirst at FT.com
09:47AM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
07:14AM  UPDATE - Alcon investor expects Novartis to raise offer at Reuters
04:48AM  Stock futures signal rebound after selloff Reuters
04:32AM  U.S. stock futures signal rebound after selloff at Reuters
04:04AM  UPDATE - Alcon investor expects Novartis to raise offer at Reuters
24-Jan-10 09:00AM  Alcon and Novartis Still Not Seeing Eye to Eye at Seeking Alpha
22-Jan-10 04:37PM  Exxon Mobil, Alcon: Money Flow Leaders (XOM, ACL) at The Wall Street Journal Online
08:53AM  PREVIEW-Big Pharma faces tougher 2010 despite US boost at Reuters
21-Jan-10 11:00AM  Novartis Offer Inadequate for Alcon Zacks.com
07:18AM  Wall Street Breakfast: Must-Know News at Seeking Alpha
20-Jan-10 04:49PM  Those Are Fighting Words at Motley Fool
04:01PM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
03:15PM  Alcon Strengthens Pipeline Zacks.com
02:14PM  [$$] Alcon Independent Directors Rebuff Novartis Offer at The Wall Street Journal Online
11:46AM  UPDATE - Alcon directors say Novartis bid grossly inadequate at Reuters
11:14AM  Another Deal for Novartis Zacks.com
11:13AM  Alcon calls Novartis offer 'grossly inadequate' at MarketWatch
09:54AM  Dividend Growth Stocks Make Attractive Buyout Targets at Seeking Alpha
09:30AM  UPDATE - Deals of the day -- mergers and acquisitions at Reuters
09:29AM  UPDATE - Alcon directors say Novartis bid grossly inadequate at Reuters
09:06AM  Panel of Alcon directors rejects Novartis bid AP
08:30AM  Independent Director Committee Determines Novartis' Merger Proposal to Minority Shareholders Call scheduled for 8:30 am ET today CCBN
07:49AM  Alcon Directors Challenge Novartis's Takeover Bid at The New York Times
07:42AM  UPDATE - Alcon directors say Novartis bid grossly inadequate at Reuters
06:53AM  UPDATE - Alcon directors say Novartis offer inadequate at Reuters
06:50AM  Alcon Group Says Novartis Bid 'Inadequate' at TheStreet.com
06:20AM  Alcon committee calls Novartis bid "inadequate" at MarketWatch
06:08AM  InPlay: Alcon independent director committee determines Novartis' merger proposal to minority shareholders of alcon is "grossly inadequate" Briefing.com
06:00AM  Alcon Independent Director Committee Determines Novartis' Merger Proposal to Minority Shareholders of Alcon is Grossly Inadequate Business Wire
19-Jan-10 07:09AM  Alcon buys rights to 2 approved eye medications AP
18-Jan-10 05:48PM  Alcon to Purchase Rights to Sirion's Eye-Care Products at Fox Business
04:00PM  Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion Business Wire
17-Jan-10 06:00PM  Novartis spurs investor fight for equality at FT.com
15-Jan-10 06:05PM  ASRT, others donate to Haiti relief at bizjournals.com
14-Jan-10 01:29PM  That Novartis-Alcon Deal May Have a Tax Problem at The Wall Street Journal Online
09:25AM  Wall to Wall Street Coverage: Upgrades and Downgrades Minyanville
09:15AM  Lennar: Analysts' Upgrades, Downgrades at TheStreet.com
06:51AM  Alcon downgraded by Citigroup Briefing.com
13-Jan-10 07:21PM  Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Alcon Inc. - ACL Business Wire
02:03PM  Brower Piven Announces Investigation of Alcon, Inc. Business Wire
01:39PM  Alcon Acquisition Will Open New Door for Novartis at Seeking Alpha
01:00PM  RPT-DEALTALK-Novartis may nudge up bid for rest of Alcon at Reuters
12:49PM  RPT-DEALTALK-Novartis may nudge up bid for rest of Alcon at Reuters
06:02AM  DEALTALK-Novartis may nudge up bid for rest of Alcon at Reuters
05:59AM  Novartis' bid to buy out Alcon at Reuters
12-Jan-10 04:50PM  Novartis to Buy Out Alcon from Nestle at BusinessWeek
04:37PM  Alcon Announces Fourth Quarter 2009 Financial Release and Conference Call Dates Business Wire
04:15PM  Alcon CEO to recuse himself from takeover decision at Reuters
03:07PM  Alcon CEO to recuse himself from takeover decision at Reuters
11:03AM  Biotech Stocks: Novartis leads drug stocks lower at MarketWatch
07:10AM  Wall Street Breakfast: Must-Know News at Seeking Alpha
03:54AM  Novartis Eyes an Opportunity in Alcon at Seeking Alpha
11-Jan-10 11:50PM  / CORRECTION - Shareholders File Lawsuit Against Novartis & Alcon Over Merger -- KSF Announces Lawsuit Marketwire
03:48PM  [$$] Stocks in the Spotlight Monday at Barrons.com
02:47PM  Pension fund sues Alcon, Novartis, Nestle over deal at Reuters
02:45PM  What to Do With That Holiday Cash at Motley Fool
02:34PM  Novartis Looks For 20/20 Vision With Alcon at Investopedia
02:34PM  Shareholders File Lawsuit Against Novartis & Alcon Over Merger -- KSF Announces Lawsuit Marketwire
02:20PM  Alcon to line up Novartis bid defence at FT.com
12:40PM  Shareholders Foundation Announces Alcon, Inc. Investor Lawsuit Against Novartis AG Offer GlobeNewswire
08:47AM  Minority shareholders seek to slow Alcon takeover AP
10-Jan-10 03:42AM  Biotech Gets a Strong Start in Financing for the New Year at Seeking Alpha
09-Jan-10 07:12AM  [$$] Charting The Market at Barrons.com
08-Jan-10 05:43PM  Novartis and Alcon: Is the Other Shoe About to Drop? at Seeking Alpha
07-Jan-10 06:03PM  A New Direction for Nestle? Morningstar.com
05:57PM  NovaBay Pharmaceuticals to Present at the Annual OneMedPlace Finance Forum Marketwire
12:04PM  UPDATE - Nestle CFO sees only small confectionery buys at Reuters
Alcon, Inc. engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally. The company offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. Its ophthalmic surgical products consist of surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. The company's consumer eye care products include contact lens care products, such as disinfecting solutions, cleaners, and lens rewetting drops; vision care products, including artificial tears to treat dry eye syndrome and ocular vitamins, as well as dietary supplements, such as Age Related Eye Disease Study Formula, Lutein, and Zeaxanthin formula. Alcon sells its pharmaceutical products to physicians, distributors, wholesalers, hospitals, government agencies, and large retailers; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and consumer eye care products directly to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It has collaboration with River Plate Biotechnology, Inc. and AstraZeneca plc; and research and licensing agreement with PhiloGene Inc. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestle S.A.